AML, CML, ALL, CLL
Acute Myeloid Leukemia (AML)
- Definition: Malignant proliferation of myeloblasts (>20% blasts in bone marrow).
- Common in: Adults, especially >60 years.
- Risk factors: Previous chemotherapy/radiation, myelodysplastic syndromes, exposure to benzene.
- Presentation: Fatigue, anemia, infections, bleeding (petechiae, bruising).
- Labs:
- ↑ WBC with blasts
- ↓ Platelets, anemia
- Auer rods (pathognomonic)
- Diagnosis: Bone marrow biopsy showing >20% myeloblasts.
- Treatment:
- Induction chemotherapy (e.g., cytarabine + anthracycline)
- Possible allogeneic stem cell transplant
- t(15;17) in APML subtype treated with All Trans Retinoic Acid (ATRA)
Chronic Myeloid Leukemia (CML)
- Definition: Myeloproliferative disorder with uncontrolled production of mature granulocytes.
- Genetics: Philadelphia chromosome t(9;22) → BCR-ABL fusion gene (constitutive tyrosine kinase activity).
- Presentation: Often asymptomatic or fatigue, weight loss, splenomegaly, night sweats.
- Labs:
- Increased hematopoietic proliferation
- Markedly elevated WBC count (leukocytosis) with left shift (myelocytes, metamyelocytes)
- Basophilia/eosinophilia is common
- Low LAP score (differentiates from leukemoid reaction)
- Increased hematopoietic proliferation
- Phases: Chronic → Accelerated → Blast crisis
- Treatment:
- Tyrosine kinase inhibitors (imatinib, dasatinib)
- Allogeneic stem cell transplant for blast crisis or refractory disease
Acute Lymphoblastic Leukemia (ALL)
- Definition: Malignant proliferation of lymphoblasts (>20% blasts).
- Common in: Children (the most common childhood leukemia), but also adults.
- Presentation: Fatigue, fever, bleeding, bone pain, lymphadenopathy, hepatosplenomegaly, CNS symptoms (headache, vomiting).
- Labs:
- ↑ WBC (leukocytosis) with lymphoblasts
- Large nucleus (scant cytoplasm), visible nucleolus
- Anemia, thrombocytopenia
- ↑ WBC (leukocytosis) with lymphoblasts
- Diagnosis: Bone marrow biopsy with >20% lymphoblasts; TdT+ (terminal deoxynucleotidyl transferase).
- Subtypes: B-ALL (most common), T-ALL (often mediastinal mass).
- Treatment: Chemotherapy + CNS prophylaxis (intrathecal methotrexate).
- Prognosis: Good in children, worse in adults.
- Associations: Down syndrome (risk for ALL and AML).
Chronic Lymphocytic Leukemia (CLL)
- Definition: Clonal proliferation of mature, small CD5+ B lymphocytes.
- Common in: Older adults (>60 years).
- Presentation: Often asymptomatic, lymphadenopathy, hepatosplenomegaly, “B symptoms” (fever, night sweats, weight loss), autoimmune hemolytic anemia.
- Labs:
- Lymphocytosis with small mature lymphocytes
- Smudge cells on peripheral smear
- Diagnosis: Flow cytometry showing CD5+, CD19+, CD20+ B cells.
- Treatment: Observation if asymptomatic; chemo/immunotherapy if symptomatic.
- Complications: Richter transformation (to aggressive lymphoma).
AML (Acute Myeloid Leukemia):
- More common in adults (median ~65 years) but can occur at any age
- Acute symptoms similar to ALL (fatigue, infections, bleeding)
- Sometimes gum hypertrophy, skin lesions (myeloid sarcoma)
- Peripheral smear: myeloblasts, Auer rods
CML (Chronic Myeloid Leukemia):
- Typically affects adults (40-60 years)
- Chronic phase: often asymptomatic or fatigue, splenomegaly
- Labs: very high WBC count with left shift (all myeloid precursors)
- Presence of Philadelphia chromosome (BCR-ABL)
- May progress to blast crisis (like AML)
ALL (Acute Lymphoblastic Leukemia):
- Most common in children (peak 2-5 years)
- Acute onset of fatigue, fever, bleeding (due to marrow failure)
- Often bone pain and lymphadenopathy
- May present with a mediastinal mass (especially T-cell ALL)
- Peripheral smear: lymphoblasts
CLL (Chronic Lymphocytic Leukemia):
- Usually affects older adults (>60)
- Often asymptomatic, found incidentally on CBC
- Symptoms when present: painless lymphadenopathy, fatigue
- Peripheral smear: smudge cells, mature small lymphocytes
- Slow progression
Hodgkin’s Lymphoma:
- Biphasic age distribution: young adults and >55 years
- Presents with painless lymphadenopathy (often cervical)
- Classic B symptoms (fever, night sweats, weight loss)
- Diagnosis requires lymph node biopsy showing Reed-Sternberg cells
Understanding Hodgkins Lymphoma
Hodgkin’s lymphoma (also known as Hodgkin’s disease) is a type of cancer that affects the lymphatic system and originates from B cells, which are important components of our immune system responsible for the memory and development of antibodies. Who Does Hodgkin’s Lymphoma Affect? Hodgkin’s lymphoma has a bimodal distribution, meaning
- Child with acute fatigue, bone pain, mediastinal mass → ALL
- Older adult with high WBC, splenomegaly, Philadelphia chromosome → CML
- Older adult with painless lymphadenopathy, smudge cells on smear → CLL
- Adult with acute gum hypertrophy, infections, blasts with Auer rods → AML
- Young adult with painless cervical lymphadenopathy, night sweats → Hodgkin’s lymphoma
Leukemoid Reaction
- A reactive, benign, marked increase in white blood cells (usually neutrophils) in response to infection or stress, mimicking leukemia.
- Causes:
- Severe bacterial infections (e.g., Clostridium difficile, C. diphtheriae)
- Stress, trauma, and inflammation
- Certain drugs (e.g., corticosteroids)
- Hemolysis or hemorrhage
- WBC count: Very high, often >50,000/µL, with increased mature neutrophils and band forms.
- Peripheral smear: Left shift (increased bands, metamyelocytes, myelocytes), but no blasts.
- Key differentiators from CML:
- High LAP score in leukemoid reaction vs. low in CML.
- Negative Philadelphia chromosome/BCR-ABL gene
- No basophilia in leukemoid reaction.
- Management: Treat underlying cause; leukemoid reaction resolves.
